News

ARK Invest's Strategic Moves: Buying GitLab, Selling Palantir

ARK Invest's Strategic Moves: Buying GitLab, Selling Palantir

ARK Invest Focuses on GitLab Amid Market Adjustments

Cathie Wood's ARK Invest continues to make waves in the financial markets with their most recent trading activity, specifically in the tech and biotech sectors. Among the notable moves, ARK's flagship ARKK ETF has strengthened its investment in GitLab Inc (NASDAQ:GTLB). In a significant transaction, ARK acquired 219,606 shares of GitLab, valued at around $13.3 million. This remarkable increase in holdings illustrates ARK's steadfast confidence in GitLab's potential in the DevOps landscape, especially following an earlier purchase of nearly 270,000 shares just days before.

Shifts in Position as ARK Sells Shares of Palantir Technologies

In a contrasting approach, ARK made a decisive move by decreasing its stake in Palantir Technologies Inc (NASDAQ:PLTR). The firm divested 103,410 shares worth approximately $8.5 million, marking an ongoing pattern of sell-offs in this data analytics powerhouse. Just a few days prior, ARK had reduced its holdings by 42,000 shares on December 24th and again sold over 22,000 shares on December 23rd, showing a clear strategy to scale back their investment in Palantir.

Trimming Holdings in Block Inc

ARK Invest also lightened its portfolio regarding Block Inc (NASDAQ:SQ), previously known as Square. The ETF sold 15,342 shares, which totaled around $1.4 million. This transaction follows a prior sell-off of over 23,000 shares just two days earlier, suggesting a broader strategy within ARK's investment framework as they optimize their asset positions.

Boosting Investment in CRISPR Therapeutics

Furthermore, ARK demonstrated its commitment to the biotech sector by boosting its stake in CRISPR Therapeutics AG (NASDAQ:CRSP). The ETF purchased 57,889 shares with a total value of approximately $2.4 million, nearly doubling down on its existing coverage of the innovative gene-editing firm. This move follows ARK's trend of increasing investments in CRISPR, as seen with their acquisition of over 35,000 shares on December 24th.

Smaller Acquisitions Reflecting Strategic Focus

In smaller transactions, ARK has also added 10X Genomics Inc (NASDAQ:TXG) to its portfolio, acquiring a modest amount of 9,256 shares across its various ETFs with a total valuation around $136,000. Meanwhile, they continued to trim their holdings in Adaptive Biotechnologies Corp (NASDAQ:ADPT) and Veracyte Inc (NASDAQ:VCYT), selling 75,957 and 741 shares, respectively. These transactions illustrate ARK's strategic adjustments as they balance their investments amid evolving market conditions.

Overall Trends in ARK's Investment Strategy

As investors monitor ARK's activities, it's evident that the team is making selective choices with a dual approach of targeted buying and strategic sell-offs. Cathie Wood and her team focus on innovative companies that present growth opportunities, using each transaction as a means to adapt to the fluctuating market landscape. Their ongoing commitment to sectors such as tech and biotech highlights an investment philosophy that desires to capitalize on future trends while managing risks accordingly.

Frequently Asked Questions

What recent trades has ARK Invest made?

ARK Invest recently purchased shares of GitLab while reducing its holdings in Palantir and Block.

Why is ARK Invest buying GitLab stock?

ARK is increasing its position in GitLab due to their confidence in the company's growth potential within the DevOps space.

What is Cathie Wood's strategy with Palantir?

Cathie Wood's ARK has been selling Palantir shares, indicating a strategic pullback from their investment in the company.

How much is ARK investing in CRISPR Therapeutics?

ARK invested approximately $2.4 million in CRISPR Therapeutics by acquiring 57,889 shares recently.

What does ARK's trading activity suggest about its investment approach?

ARK's trading activities suggest a balanced approach of targeted buying and selective selling, aligning investments with innovative growth prospects.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 54

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 141

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Thanksgiving in Outer Banks: Unique Traditions Await

Updated Category News Views 115

Thanksgiving Plans Off the Beaten Path Thanksgiving in the Outer Banks isn't just another holiday; it's a whole different ball game. Imagine trading in the usual family couch-potato marathon for a beachside gathering, where the sand replaces the snow, and coastal seafood joins the turkey on your dinner table. If you've been teetering on the edge of making plans, this...

Continue Reading
AI Deception Challenges the Confidence of Fraud Defenses

Updated Category News Views 145

Fraud Week Spotlights AI Deception Alright, here's the rub: we're in Fraud Week 2026, and boy, is AI shaking the foundations of yesterday's fraud defenses! With all this AI talk, you would expect systems to be near invincible by now. But reality? A different beast altogether. AI has this knack of tripling up the complexity while pretending to solve it, making traditional...

Continue Reading
LA Fitness ELEVATE Opens at RITHM: A New Era Dawns

Updated Category News Views 66

Elevating Fitness at RITHM: A New Era Has Begun RD Management just dropped a new ace in Tampa Bay’s hand—LA Fitness ELEVATE at the RITHM at Uptown. They lit up the scene with this 30,000-square-foot beast of a gym, and I’ll tell you, it’s not your standard run-of-the-mill joint. When you toss twelve-and-a-half million bucks into a pot, you're aiming to lure folks...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 85

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
FiEE Rockets to Profitability with 382% Revenue Surge

Updated Category News Views 188

Big Moves in the Tech Jungle: FiEE's Comeback Let's chew the fat on FiEE, Inc., a company that's left its hardware-heavy past in the dust and grabbed the bull by the horns with fresh, AI-driven brand tech solutions. We're talking a whopping 382.1% revenue increase. Now, that's not chump change. From barely scraping $2 million last year to raking in $9.6 million just for...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 50

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Koppers Faces SEC Scrutiny After Earnings Miss

Updated Category News Views 182

Koppers' Third-Quarter Blues: Missing the Mark Koppers Holdings Inc. (NYSE: KOP) took a hard hit this quarter, missing Wall Street's earnings expectations by a mile. The adjusted earnings per share came in at just $0.77, while the suits down on Wall Street were expecting something closer to $1.34 to $1.37. Now, if you’re holding KOP in your portfolio, you're probably...

Continue Reading
Terra Kaffe's Big Win with Oprah's Endorsement

Updated Category News Views 109

Terra Kaffe Hits the Jackpot with Oprah Sometimes, destiny has a way of handing out golden tickets, and for Terra Kaffe, receiving a nod from Oprah Winfrey's revered list of Favorite Things for 2026 is nothing short of that. I mean, you can't underestimate the pull Mrs. O has. Her endorsement isn’t just another celebrity pat-on-the-back, it’s a megaphone blaring...

Continue Reading

Top 5 Most Recently Viewed Articles

LLCP Promotions: A Positive Spin or a Prelude to Trouble?

Updated Category News Views 211

Levine Leichtman Capital Partners (LLCP) just gave its Finance and Administration team a shake-up with promotions announced on February 17, 2026. Sure, the firm hails from Los Angeles—where they like to keep things sunny—but these moves might be less about shining futures and more about staving off trouble. Who’s Climbing the LLCP Ladder? Key Players Promoted...

Continue Reading
Understanding Novo Nordisk's Market Sentiment and Trends

Updated Category News Views 187

Novo Nordisk's Current Short Interest Overview Novo Nordisk's short percent of float has decreased substantially, reflecting a 7.89% drop since its last report. The company has disclosed that there are currently 23.58 million shares sold short. This figure corresponds to around 0.7% of all the shares that are available for public trading. Given the trading activity,...

Continue Reading
LG Innotek Launches Innovative Digital Key to Transform Driving

Updated Category News Views 226

Revolutionizing Vehicle Access with Innovative Technology LG Innotek has introduced an exciting new product, the 'Next-generation Digital Key Solution'. This innovative technology connects smartphones to vehicles, allowing users to lock and unlock doors and start engines seamlessly through wireless communication. The digital key’s unique design eliminates the risk of...

Continue Reading
Exciting Opportunities: Auction Details for Office Properties

Updated Category News Views 318

Exciting Opportunities: Auction Details for Office Properties Hilco Real Estate Sales has recently announced an upcoming auction featuring two prominent office buildings designed to capture interest from investors and developers alike. Set in highly visible locations, these properties are prime candidates for a range of investment opportunities. Auction Announcement The...

Continue Reading
Grease Monkey and SpeeDee Oil Change Celebrate Franchise Success

Updated Category News Views 243

Grease Monkey and SpeeDee Oil Change Shine in Franchise Rankings Grease Monkey and SpeeDee Oil Change have recently made headlines after securing their spots in the coveted Franchise Times Top 400 list. This recognition showcases their growth and resilience in the automotive service sector, highlighting the commitment to providing excellent service to their customers. A...

Continue Reading